Ardian-backed Théradial completed the acquisition of Taurosept from Geistlich Pharma.

Ardian-backed Théradial, a company focused on providing high-quality information and solutions to healthcare professionals, completed the acquisition of Taurosept, an antimicrobial catheter lock solution, from Geistlich Pharma, a medtech company. Financial terms were not disclosed. "This acquisition marks a pivotal moment for our company. It reflects our commitment to providing high-value solutions, both in France and internationally," Frédéric Le Pottier, Théradial Group President.